Skip to content

Insider · CIK 0002103809

Mark Lawrence Rubinstein

officer

Files at ACHV (ACHIEVE LIFE SCIENCES, INC.). First filing -, latest -.

In brief

Mark Lawrence Rubinstein files SEC Form 4 as officer at ACHV (ACHIEVE LIFE SCIENCES, INC.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Mark Lawrence Rubinstein has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 1 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jan 28, 2026ACHV
ACHIEVE LIFE SCIENCES, INC.
AGrant or award
Stock Option (right to buy)derivative
+180,000$0.00$0180,000Jan 30, 2026

Questions about Mark Lawrence Rubinstein

Answered from the filings on this page, as of the latest one.

Is Mark Lawrence Rubinstein buying or selling?

Mark Lawrence Rubinstein has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Mark Lawrence Rubinstein's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Mark Lawrence Rubinstein has 0.

Where does Mark Lawrence Rubinstein file Form 4?

Mark Lawrence Rubinstein has filed Form 4 at ACHV (ACHIEVE LIFE SCIENCES, INC.) as Chief Medical Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Mark Lawrence Rubinstein: insider trades and track record | InsiderTell